PXD064572

PXD064572 is an original dataset announced via ProteomeXchange.

Title	Proteomic analysis of CDK4/6 inhibition in T47D cells
Description	CDK4/6 inhibitors have emerged in combination with hormone therapy as an effective treatment for HR+/HER2- breast cancer. Despite the clinical success of these drugs, challenges such as varied patient response and acquired resistance remain a significant treatment barrier. To better understand the mechanisms by which breast cancer cells respond to CDK4/6 inhibition, we conducted a multi-omics analysis in T-47D breast cancer cells profiling Palbociclib-induced changes at the gene expression, alternative splicing, and proteomic levels. We report that cell division and proliferation-related genes are often downregulated and also subject to alternative splicing changes. Additionally, we find an upregulation of estrogen response-related genes, suggesting negative feedback between CDK4/6 and upstream hormone signaling. Intriguingly, we observe an upregulation of Cyclin D1 (consistent with previous literature) but not Cyclin D3, indicating distinct and specific roles for these cyclins in the Palbociclib response. Finally, we observe that Palbociclib broadly downregulates genes essential for cell proliferation and survival, and that co-targeting CDK7 in combination additively affects proliferation, suggesting combination strategies which might be used to achieve improved therapeutic benefit. Our findings reveal both the broad patterns and specific gene- and protein-level changes that result from Palbociclib treatment, providing a key resource in understanding the response to CDK4/6 inhibitors for researchers and clinicians to improve breast cancer treatments and expand the use of CDK4/6 inhibitors to other cancers.
HostingRepository	PRIDE
AnnounceDate	2026-02-23
AnnouncementXML	Submission_2026-02-22_17:39:23.355.xml
DigitalObjectIdentifier
ReviewLevel	Peer-reviewed dataset
DatasetOrigin	Original dataset
RepositorySupport	Unsupported dataset by repository
PrimarySubmitter	Scott Lyons
SpeciesList	scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606;
ModificationList	monohydroxylated residue; iodoacetamide derivatized residue
Instrument	Orbitrap Exploris 480

Revision	Datetime	Status	ChangeLog Entry
0	2025-06-03 11:14:40	ID requested
⏵ 1	2026-02-22 17:39:24	announced

Kavalipati A, Aponte A, Sullivan ME, Whittington SL, Mart, í, nez JC, Goda GA, Aleman MM, Emanuele MJ, Dominguez D, Charting the multilevel molecular response to palbociclib in ER-positive breast cancer. NAR Cancer, 8(1):zcag003(2026) [pubmed]

10.1093/narcan/zcag003;

submitter keyword: breast cancer, RB,cell cycle, CDK4/6, Palbociclib

Michael Emanuele
contact affiliation	UNC LCCC, Pharmacology
contact email	emanuele@email.unc.edu
lab head
Scott Lyons
contact affiliation	UNC Chapel Hill
contact email	scott_lyons@med.unc.edu
dataset submitter

Dataset FTP location NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/02/PXD064572

PRIDE project URI

• PRIDE
  1. PXD064572
     1. Label: PRIDE project
     2. Name: Proteomic analysis of CDK4/6 inhibition in T47D cells